Epco Hasker1, Andrew Hope2, Emmanuel Bottieau3. 1. Department of Public Health, Institute of Tropical Medicine, Antwerp, Belgium. 2. Liverpool School of Tropical Medicine, Liverpool, UK. 3. Department of Clinical Sciences, Institute of Tropical Medicine, Antwerp, Belgium.
Abstract
PURPOSE OF REVIEW: Gambiense human African trypanosomiasis (gHAT), a disease that has killed hundreds of thousands as recently as the 1990s, could be on the verge of elimination or even eradication. This review describes recent developments that give us reasons for optimism as well as some caveats. RECENT FINDINGS: New developments in diagnostic and vector control tools, and especially in treatment, make it possible to strive for elimination of transmission of gHAT by 2030, perhaps even eradication. SUMMARY: Gambiense human African trypanosomiasis is a deadly infectious disease affecting West and Central Africa, South Sudan and Uganda, and transmitted between humans by tsetse flies. The disease has caused several major epidemics, the latest one in the 1990s. Thanks to recent innovations such as rapid diagnostic tests for population screening, a single-dose oral treatment and a highly efficient vector control strategy, interruption of transmission of the causative parasite is now within reach. If indeed gHAT has an exclusively human reservoir, this could even result in eradication of the disease. Even if there were an animal reservoir, on the basis of epidemiological data, it plays a limited role. Maintaining adequate postelimination surveillance in known historic foci, using the newly developed tools, should be sufficient to prevent any future resurgence.
PURPOSE OF REVIEW: Gambiense human African trypanosomiasis (gHAT), a disease that has killed hundreds of thousands as recently as the 1990s, could be on the verge of elimination or even eradication. This review describes recent developments that give us reasons for optimism as well as some caveats. RECENT FINDINGS: New developments in diagnostic and vector control tools, and especially in treatment, make it possible to strive for elimination of transmission of gHAT by 2030, perhaps even eradication. SUMMARY: Gambiense human African trypanosomiasis is a deadly infectious disease affecting West and Central Africa, South Sudan and Uganda, and transmitted between humans by tsetse flies. The disease has caused several major epidemics, the latest one in the 1990s. Thanks to recent innovations such as rapid diagnostic tests for population screening, a single-dose oral treatment and a highly efficient vector control strategy, interruption of transmission of the causative parasite is now within reach. If indeed gHAT has an exclusively human reservoir, this could even result in eradication of the disease. Even if there were an animal reservoir, on the basis of epidemiological data, it plays a limited role. Maintaining adequate postelimination surveillance in known historic foci, using the newly developed tools, should be sufficient to prevent any future resurgence.
Authors: Andreas K Lindner; Veerle Lejon; François Chappuis; Jorge Seixas; Leon Kazumba; Michael P Barrett; Erick Mwamba; Olema Erphas; Elie A Akl; Gemma Villanueva; Hanna Bergman; Pere Simarro; Augustin Kadima Ebeja; Gerardo Priotto; Jose Ramon Franco Journal: Lancet Infect Dis Date: 2019-12-23 Impact factor: 25.071
Authors: P Mitashi; E Hasker; F Mbo; J P Van Geertruyden; M Kaswa; C Lumbala; M Boelaert; P Lutumba Journal: Trop Med Int Health Date: 2014-10-20 Impact factor: 2.622
Authors: Philippe Büscher; Jean-Mathieu Bart; Marleen Boelaert; Bruno Bucheton; Giuliano Cecchi; Nakul Chitnis; David Courtin; Luisa M Figueiredo; José-Ramon Franco; Pascal Grébaut; Epco Hasker; Hamidou Ilboudo; Vincent Jamonneau; Mathurin Koffi; Veerle Lejon; Annette MacLeod; Justin Masumu; Enock Matovu; Raffaele Mattioli; Harry Noyes; Albert Picado; Kat S Rock; Brice Rotureau; Gustave Simo; Sophie Thévenon; Sandra Trindade; Philippe Truc; Nick Van Reet Journal: Trends Parasitol Date: 2018-01-23
Authors: Crispin Lumbala; Paul R Bessell; Pascal Lutumba; Sylvain Baloji; Sylvain Biéler; Joseph M Ndung'u Journal: PLoS One Date: 2017-07-03 Impact factor: 3.240